Clinical Trials Directory

Trials / Unknown

UnknownNCT05211427

Bitter Taste Receptors in Oropharynx Cancer

Expression of Bitter Taste Receptors in Oropharynx Carcinoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Thomas Hummel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this work is to investigate the expression of the bitter taste receptors in p16-positive and negative oropharyngeal carcinomas (in comparison to healthy, local tissue).

Detailed description

Goal setting The aim of this work is to investigate the expression of the bitter taste receptors in p16-positive and negative oropharyngeal carcinomas (in comparison to healthy, local tissue). The hypothesis is that oropharyngeal carcinomas express TAS2Rs and that their stimulation can induce apoptosis. The lower expression of certain TAS2Rs in the tumor cells could represent protection from apoptosis by stimulation with the bitter ligands. Alternatively, it could polymorphisms of the bitter taste receptors, which can influence their function independently of the expression. In order to address the question of general bitter sensitivity in more detail, the investigators are planning to carry out a bitter taste test on the test subjects. methodology As this is a pilot study, the investigators limit the number of subjects to 10 patients with p-16 positive and negative oropharyngeal squamous cell carcinoma and 10 patients with acute recurrent tonsillitis or other benign pathology in pharynx. The expression analysis is carried out using qPCR and possibly immunohistochemical methods. Taste strips are used for the taste tests. Cognitive interest The results of this study will provide important insight into the pathophysiology of oropharyngeal cancers and possibly all TAS2R-expressing cancers. In addition, this and further studies can create a theoretical basis for new therapeutic methods for this group of diseases.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiopsyBiopsy of an oropharynx tumor or of a healthy oropharynx mucosa

Timeline

Start date
2021-03-23
Primary completion
2025-02-01
Completion
2025-07-01
First posted
2022-01-27
Last updated
2023-03-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05211427. Inclusion in this directory is not an endorsement.